Bruxism as a Side Effect of Ramelteon or Seroquel
Neither ramelteon nor quetiapine (Seroquel) are documented to cause bruxism; in fact, quetiapine has been specifically reported to treat SSRI-induced bruxism rather than cause it.
Ramelteon and Bruxism
Ramelteon, a melatonin receptor agonist, has no documented association with bruxism in either its FDA labeling or clinical guidelines. The FDA label for ramelteon 1 lists extensive adverse effects including:
- Severe anaphylactic reactions
- Abnormal thinking and behavioral changes
- Complex sleep behaviors (sleep-driving, sleep-eating)
- Reproductive hormone effects (decreased testosterone, increased prolactin)
- CNS depression
Bruxism is notably absent from this comprehensive adverse effect profile. Clinical practice guidelines 2 evaluating ramelteon for chronic insomnia found no evidence of bruxism or movement disorders as adverse events, with studies showing "no evidence of significant difference from placebo for any adverse events" 2.
Quetiapine (Seroquel) and Bruxism
The relationship between quetiapine and bruxism is paradoxical—rather than causing bruxism, quetiapine appears to treat it:
Evidence Against Causation:
- The FDA label for Seroquel 3 extensively documents adverse effects including extrapyramidal symptoms (EPS), dystonia, akathisia, and numerous movement disorders
- Bruxism is not listed among the comprehensive adverse reaction tables covering thousands of patients in clinical trials
- The label specifically addresses EPS using four measurement methods, with no mention of bruxism or teeth grinding
Evidence for Therapeutic Effect:
Quetiapine has been successfully used to treat bruxism, particularly when caused by SSRIs. A case series 4 demonstrated that low-dose quetiapine (25-50 mg daily) effectively resolved SSRI-induced bruxism in 5 patients within days. The proposed mechanism involves quetiapine's potent 5-HT2 receptor antagonism counteracting the serotonergic effects that trigger bruxism.
The Actual Culprits: Antipsychotics and SSRIs
While quetiapine itself doesn't cause bruxism, other medications do:
High-Risk Medications:
SSRIs and SNRIs: Strong association with bruxism development 5, 6, 7
First-generation antipsychotics: Associated with bruxism as part of extrapyramidal side effects 8, 9
- Mechanism involves dopaminergic system disruption
- Often coupled with akathisia
Dopaminergic drugs: Both agonists (L-DOPA, psychostimulants) and antagonists can trigger bruxism 10
Important Clinical Distinction:
The literature on antipsychotics and bruxism 8, 9, 10 primarily references typical (first-generation) antipsychotics and their dopamine-blocking effects. Quetiapine, as an atypical antipsychotic with unique receptor binding properties (more potent 5-HT2 than D2 blockade), behaves differently and may actually ameliorate rather than cause bruxism.
Clinical Implications
If a patient on ramelteon or quetiapine develops bruxism:
- Look elsewhere for the cause—review all medications, particularly SSRIs, SNRIs, or stimulants
- Consider underlying psychiatric conditions (anxiety, depression, stress) as independent risk factors 5
- Evaluate for substance use (caffeine, nicotine, recreational drugs) 9
- Do not discontinue quetiapine if it's being used for psychiatric indications, as it may actually help manage bruxism
If treating SSRI-induced bruxism:
- Consider adding low-dose quetiapine (25-50 mg) as adjunctive therapy 4
- Alternative: propranolol has shown efficacy for antipsychotic-induced bruxism 8
Evidence Quality Note
The bruxism literature is predominantly based on case reports and observational studies 9, 6. Most evidence relies on self-reported or clinically-reported bruxism rather than polysomnography, and few studies prospectively assess bruxism before and after medication initiation while controlling for psychological confounders 6. This methodological limitation means causation is difficult to establish definitively, but the pattern is clear: ramelteon and quetiapine are not implicated as causes of bruxism.